The objective of this project is to support Botanical Solutions to use QS-21 in innovative vaccines, including the COVID-19 candidate. Supporting this project will allow the increase in manufacturing, marketing, and sales the next 12-18 months, enabling the delivery of vaccines for mass adoption at a significantly lower cost compared to conventional vaccines that will allow safe immunization at home (or any preferable point of care)in the near future. The impact of this vaccine method is of global reach for the cost and ease of use.

Project Detail

Country

Chile

Project Number

CH-L1156

Approval Date

July 17, 2020

Project Status

Closed

Project Type

Loan Operation

Sector

HEALTH

Subsector

DISEASE PREVENTION & CONTROL

Lending Instrument

Instrumento del Fondo Multilateral de Inversiones

Lending Instrument Code

MIF

Modality

-

Facility Type

-

Environmental Classification

Likely to cause minimal or no negative environmental and associated social impacts

Total Cost

USD 8,000,000.00

Country Counterpart Financing

USD 0.00

Original Amount Approved

USD 1,000,000.00
Financial Information
Operation Number Lending Type Reporting Currency Reporting Date Signed Date Fund Financial Instrument
5079/MS-CH Non-Sovereign Guaranteed USD - United States Dollar MIF-Small Enterprise Investment Fund MIF Financing
Operation Number 5079/MS-CH
  • Lending Type: Non-Sovereign Guaranteed
  • Reporting Currency: USD - United States Dollar
  • Reporting Date:
  • Signed Date:
  • Fund: MIF-Small Enterprise Investment Fund
  • Financial Instrument: MIF Financing

Can’t find a document? Request information

 Implementation Phase
https://www.iadb.org/document.cfm?id=EZSHARE-400553345-1
Donors Memorandum
CH-L1156 Executive Summary.pdf
Feb. 08, 2022
English

Have an Environmental or Social issue related to IDB projects? File a Complaint